Not available
Quote | Cytokinetics Incorporated (NASDAQ:CYTK)
Last: | $59.69 |
---|---|
Change Percent: | -1.91% |
Open: | $59.62 |
Close: | $59.69 |
High: | $61.38 |
Low: | $58.5 |
Volume: | 1,166,218 |
Last Trade Date Time: | 07/26/2024 03:00:00 am |
News | Cytokinetics Incorporated (NASDAQ:CYTK)
SOUTH SAN FRANCISCO, Calif., July 25, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that it is scheduled to report second quarter results on August 8, 2024 at 4:00 PM Eastern Time. Following the announcement, Cytokinetics’ senior management will host a ...
2024-07-25 07:00:04 ET Summary The Tema Obesity & Cardiometabolic ETF is a new actively managed fund focusing on the obesity treatment market. The investment strategy includes a mix of cash flow-positive companies, high-growth companies, and start-ups with promising technology...
Message Board Posts | Cytokinetics Incorporated (NASDAQ:CYTK)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $CYTK News Article - Cytokinetics Releases Inaugural Corporate Responsibility Report | whytestocks | investorshangout | 03/27/2023 7:46:03 PM |
Wow never seen a stock move up from | Cosa | investorshub | 12/14/2022 6:33:40 PM |
Sold at $41. | H2R | investorshub | 12/14/2022 3:01:42 PM |
Sorry to anyone holding here. I hope | Cosa | investorshub | 12/14/2022 3:54:15 AM |
AdCom: 8 to 3 against! | H2R | investorshub | 12/13/2022 11:29:31 PM |
News, Short Squeeze, Breakout and More Instantly...
Cytokinetics Incorporated Company Name:
CYTK Stock Symbol:
NASDAQ Market:
Cytokinetics Incorporated Website:
SOUTH SAN FRANCISCO, Calif., July 25, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that it is scheduled to report second quarter results on August 8, 2024 at 4:00 PM Eastern Time. Following the announcement, Cytokinetics’ senior management will host a ...
Late Breaking Clinical Trial Presentations to Feature Additional Results from SEQUOIA-HCM Related to Patient-Reported Health Status, Cardiac Structure and Function and Biomarkers Analyses of Safety and Outcomes from FOREST-HCM Related to Withdrawal of Standard of Care Medications to b...
2024-06-20 20:26:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...